287 related articles for article (PubMed ID: 21111964)
21. Treatment of metastatic melanoma: an overview.
Bhatia S; Tykodi SS; Thompson JA
Oncology (Williston Park); 2009 May; 23(6):488-96. PubMed ID: 19544689
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy: Vaccine trials in melanoma -- time for reflection.
Eggermont AM
Nat Rev Clin Oncol; 2009 May; 6(5):256-8. PubMed ID: 19390551
[TBL] [Abstract][Full Text] [Related]
23. [Melanoma: Cellular and vaccinal immunotherapy].
Dréno B; Khammari A; Knol AC; Labarrière N
Bull Acad Natl Med; 2014 Feb; 198(2):309-19; discussion 319. PubMed ID: 26263706
[TBL] [Abstract][Full Text] [Related]
24. The dermis as a portal for dendritic cell-targeted immunotherapy of cutaneous melanoma.
Oosterhoff D; Sluijter BJ; Hangalapura BN; de Gruijl TD
Curr Top Microbiol Immunol; 2012; 351():181-220. PubMed ID: 21681685
[TBL] [Abstract][Full Text] [Related]
25. Making It Personal: Neoantigen Vaccines in Metastatic Melanoma.
Hellmann MD; Snyder A
Immunity; 2017 Aug; 47(2):221-223. PubMed ID: 28813655
[TBL] [Abstract][Full Text] [Related]
26. Current and future adjuvant immunotherapies for melanoma: blockade of cytotoxic T-lymphocyte antigen-4 as a novel approach.
Agarwala SS; O'Day SJ
Cancer Treat Rev; 2011 Apr; 37(2):133-42. PubMed ID: 20638184
[TBL] [Abstract][Full Text] [Related]
27. Review: dendritic cell immunotherapy for melanoma.
Hadzantonis M; O'Neill H
Cancer Biother Radiopharm; 1999 Feb; 14(1):11-22. PubMed ID: 10850282
[TBL] [Abstract][Full Text] [Related]
28. Melanoma: is immunotherapy of benefit?
Faries MB; Morton DL
Adv Surg; 2003; 37():139-69. PubMed ID: 12953631
[No Abstract] [Full Text] [Related]
29. Melanoma vaccines: developments over the past 10 years.
Klein O; Schmidt C; Knights A; Davis ID; Chen W; Cebon J
Expert Rev Vaccines; 2011 Jun; 10(6):853-73. PubMed ID: 21692705
[TBL] [Abstract][Full Text] [Related]
30. Ctla-4 blockade plus adoptive T-cell transfer promotes optimal melanoma immunity in mice.
Mahvi DA; Meyers JV; Tatar AJ; Contreras A; Suresh M; Leverson GE; Sen S; Cho CS
J Immunother; 2015; 38(2):54-61. PubMed ID: 25658614
[TBL] [Abstract][Full Text] [Related]
31. The clinical utility of cytotoxic T lymphocyte antigen 4 abrogation by human antibodies.
Weber JS
Melanoma Res; 2006 Oct; 16(5):379-83. PubMed ID: 17013086
[TBL] [Abstract][Full Text] [Related]
32. [A malignus melanoma immunterápiájának lehetoségei].
Ladányi A
Magy Onkol; 2003; 47(1):113-7. PubMed ID: 12704464
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy for melanoma.
Kim CJ; Dessureault S; Gabrilovich D; Reintgen DS; Slingluff CL
Cancer Control; 2002; 9(1):22-30. PubMed ID: 11907463
[TBL] [Abstract][Full Text] [Related]
34. Strategies to overcome obstacles to successful immunotherapy of melanoma.
Pandolfi F; Cianci R; Lolli S; Dunn IS; Newton EE; Haggerty TJ; Boyle LA; Kurnick JT
Int J Immunopathol Pharmacol; 2008; 21(3):493-500. PubMed ID: 18831916
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and management of malignant melanoma.
Goldstein BG; Goldstein AO
Am Fam Physician; 2001 Apr; 63(7):1359-68, 1374. PubMed ID: 11310650
[TBL] [Abstract][Full Text] [Related]
36. Recent advances and hurdles in melanoma immunotherapy.
Jandus C; Speiser D; Romero P
Pigment Cell Melanoma Res; 2009 Dec; 22(6):711-23. PubMed ID: 19735459
[TBL] [Abstract][Full Text] [Related]
37. [Vaccination therapy of melanoma].
Schuler-Thurner B; Schuler G
J Dtsch Dermatol Ges; 2005 Aug; 3(8):630-45. PubMed ID: 16033483
[No Abstract] [Full Text] [Related]
38. Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells.
Speiser DE; Pittet MJ; Rimoldi D; Guillaume P; Luescher IF; Liénard D; Lejeune F; Cerottini JC; Romero P
Semin Cancer Biol; 2003 Dec; 13(6):461-72. PubMed ID: 15001165
[TBL] [Abstract][Full Text] [Related]
39. HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma.
Geng H; Zhang GM; Xiao H; Yuan Y; Li D; Zhang H; Qiu H; He YF; Feng ZH
Int J Cancer; 2006 Jun; 118(11):2657-64. PubMed ID: 16425224
[TBL] [Abstract][Full Text] [Related]
40. The treatment of melanoma with an emphasis on immunotherapeutic strategies.
Jack A; Boyes C; Aydin N; Alam K; Wallack M
Surg Oncol; 2006 Jul; 15(1):13-24. PubMed ID: 16815006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]